NATALIE TRAVIS: Open Payments
NPI 1154063774 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 22 payments from 10 companies in 2025. Trend: 2023 $1,603 · 2024 $279 · 2025 $391
Food & beverage: $292Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $147 |
| ABBVIE INC. | 4 | $74 |
| Galderma Laboratories, L.P. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $25 |
| Organon LLC | 3 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| GENZYME CORPORATION | 1 | $15 |
| UCB, Inc. | 1 | $14 |
| Cipher Pharmaceuticals US LLC | 1 | $14 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, Zoryve, COSENTYX, DUPIXENT, Bimzelx, Natroba.
Industry payments across KY — which companies pay providers there.
